Arizona State Retirement System Allovir, Inc. Transaction History

Arizona State Retirement System

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$2.15 - $3.64 $8,681 - $14,698	4,038 Added 38.44%	14,544 $31,000
Q2 2023 Aug 01, 2023	SELL	$3.17 - $5.82 $9,481 - $17,407	-2,991 Reduced 22.16%	10,506 $35,000
Q1 2023 Apr 27, 2023	BUY	$3.94 - $7.05 $1,445 - $2,587	367 Added 2.8%	13,497 $53,000
Q4 2022 Feb 07, 2023	BUY	$4.7 - $9.98 $2,401 - $5,099	511 Added 4.05%	13,130 $67,000
Q3 2022 Nov 07, 2022	BUY	$4.13 - $8.79 $52,116 - $110,921	12,619 New	12,619 $100,000
Q4 2021 Feb 04, 2022	SELL	$12.94 - $25.99 $126,216 - $253,506	-9,754 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$16.97 - $25.06 $165,525 - $244,435	9,754 New	9,754 $244,000

44.6M

14.9K

200

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $40.9M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.